[HLFG] YoY Annual (Unaudited) Result on 30-Jun-2019 [#4]

Announcement Date
28-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2019
Quarter
30-Jun-2019 [#4]
Profit Trend
YoY- 0.62%
View:
Show?
Annual (Unaudited) Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 6,251,516 6,198,872 5,257,825 5,278,010 5,350,991 5,034,562 4,543,328 5.46%
PBT 4,839,979 3,971,507 3,299,521 3,505,640 3,578,585 3,089,949 2,565,038 11.15%
Tax -1,157,118 -595,146 -520,566 -591,379 -684,059 -773,065 -501,494 14.94%
NP 3,682,861 3,376,361 2,778,955 2,914,261 2,894,526 2,316,884 2,063,544 10.13%
-
NP to SH 2,452,209 2,265,254 1,857,502 1,919,359 1,907,442 1,506,765 1,358,895 10.33%
-
Tax Rate 23.91% 14.99% 15.78% 16.87% 19.12% 25.02% 19.55% -
Total Cost 2,568,655 2,822,511 2,478,870 2,363,749 2,456,465 2,717,678 2,479,784 0.58%
-
Net Worth 24,365,371 22,823,171 20,895,915 19,195,767 17,796,897 16,661,945 15,399,676 7.94%
Dividend
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Div 523,497 453,515 430,843 480,466 457,798 436,056 436,056 3.09%
Div Payout % 21.35% 20.02% 23.19% 25.03% 24.00% 28.94% 32.09% -
Equity
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Net Worth 24,365,371 22,823,171 20,895,915 19,195,767 17,796,897 16,661,945 15,399,676 7.94%
NOSH 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 0.00%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 58.91% 54.47% 52.85% 55.22% 54.09% 46.02% 45.42% -
ROE 10.06% 9.93% 8.89% 10.00% 10.72% 9.04% 8.82% -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 549.32 546.74 463.74 461.38 467.54 438.74 395.93 5.60%
EPS 216.30 199.80 163.60 167.80 166.80 131.80 123.20 9.83%
DPS 46.00 40.00 38.00 42.00 40.00 38.00 38.00 3.23%
NAPS 21.41 20.13 18.43 16.78 15.55 14.52 13.42 8.09%
Adjusted Per Share Value based on latest NOSH - 1,147,516
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
RPS 544.79 540.20 458.19 459.95 466.31 438.74 395.93 5.46%
EPS 213.70 197.40 161.87 167.26 166.22 131.80 123.20 9.60%
DPS 45.62 39.52 37.55 41.87 39.89 38.00 38.00 3.09%
NAPS 21.2331 19.8892 18.2097 16.7281 15.509 14.52 13.42 7.94%
Price Multiplier on Financial Quarter End Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 -
Price 18.50 17.80 13.10 18.54 18.00 16.80 14.68 -
P/RPS 3.37 3.26 2.82 4.02 3.85 3.83 3.71 -1.58%
P/EPS 8.59 8.91 8.00 11.05 10.80 12.79 12.40 -5.93%
EY 11.65 11.22 12.51 9.05 9.26 7.82 8.07 6.30%
DY 2.49 2.25 2.90 2.27 2.22 2.26 2.59 -0.65%
P/NAPS 0.86 0.88 0.71 1.10 1.16 1.16 1.09 -3.87%
Price Multiplier on Announcement Date
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Date 30/08/22 30/08/21 28/08/20 28/08/19 28/08/18 24/08/17 29/08/16 -
Price 19.34 18.10 12.34 16.04 18.60 16.70 16.10 -
P/RPS 3.52 3.31 2.66 3.48 3.98 3.81 4.07 -2.38%
P/EPS 8.98 9.06 7.53 9.56 11.16 12.72 13.60 -6.68%
EY 11.14 11.04 13.28 10.46 8.96 7.86 7.36 7.14%
DY 2.38 2.21 3.08 2.62 2.15 2.28 2.36 0.14%
P/NAPS 0.90 0.90 0.67 0.96 1.20 1.15 1.20 -4.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment